In addition, a decreased semaphorin 3F concentration in the amniotic fluid was already present at 16–18 weeks of gestation, potentially suggesting this anti-angiogenic factor as a predictive biomarker of preeclampsia. This evidence concerns the gene SEMA3F and preeclampsia.